The invention relates to novel betulinic acid derivatives and related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases. These compounds are esterified in position 3 and are substituted in position 17 of the betulinic acid structure, via a linking group W, by a saturated 5-7 membered nitrogen-heterocycle.
这项发明涉及新型苦药酸衍
生物和相关化合物,以及用于治疗病毒性疾病特别是HIV介导疾病的药物组合物。这些化合物在苦药酸结构的3位
酯化,并且在17位通过连接基团W被取代,取代基是饱和的5-7元
氮杂环。